In humans, however, despite evidence suggesting a role for LCMT1 and PP2A in Alzheimer's disease [68], [76], genetic variation of these genes did not appear to alter risk for late-onset Alzheimer's disease [77]. This evidence concerns the gene PTPA and Alzheimer disease.